FDA proposes curbs on mass copycats of Novo, Lilly's weight-loss drugs
- Posted on April 30, 2026
- By Usa Today
- 0 Views
- 1 min read
FDA proposes curbs on mass copycats of Novo, Lilly's weight-loss drugs
The Food and Drug Administration proposed excluding Novo Nordisk and Eli Lilly's weight-loss drugs from a key compounding list.
